Biography and Research Information
OverviewAI-generated summary
Madison McClanahan's research focuses on understanding the complexities of CD30+ T-cell lymphoma, particularly in the context of Chimeric Antigen Receptor T-cell (CAR T-cell) therapy. Their work addresses diagnostic challenges that arise in the post-immunotherapy setting, where the presence of lymphoma can be difficult to distinguish from treatment-related changes. This area of study is critical for accurate patient management and treatment planning following CAR T-cell interventions. McClanahan has one publication and one citation, with an h-index of 1. They collaborate with Michael E. Stokes at the University of Arkansas for Medical Sciences, with whom they have one shared publication.
Metrics
- h-index: 1
- Publications: 1
- Citations: 1
Selected Publications
-
Generalized Petechial‐Purpuric Eruption in a Child: A Rare Presentation of Parvovirus <scp>B19</scp> Infection (2026)
-
CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting (2025)
Collaboration Network
Top Collaborators
- CD30+ T-cell lymphoma following Chimeric Antigen Receptor T-cell therapy (CART-cell therapy): Diagnostic uncertainty in a postimmunotherapy setting
Similar Researchers
Based on overlapping research topics